Latest news

Longenesis Enters the Semi-finals of EIT Health's Catapult 2022-23

We’re proud to share that we are a semifinalist of EIT Health's Catapult 2022-23 Edition.

Thanks to this programme, and together with the rest of the “Digital Health” category startups we have received invaluable individual training from a panel of globally renowned health experts on topics ranging from pitch decks to commercialisation insights. We are also delighted to announce the launch of the EIT Health’s Catapult Videos On-Demand platform! The free-of-charge platform allows to meet Longenesis and the other 40 best biotech, medtech and digital health startups stringently pre-selected by external healthcare experts. The ventures are from all over Europe and actively looking for Seed and Series A investments.

Register now to watch us pitch!! And to connect with us and the rest of the teams and other international healthcare investors, corporates and EIT Health partners.

Find out more:

#EITHCatapult #HealthcareInnovation #MedTech #BioTech #DigitalHealth